Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Biochem J
2003 Jun 01;372Pt 2:503-15. doi: 10.1042/BJ20030174.
Show Gene links
Show Anatomy links
The structure and regulation of the human and mouse matrix metalloproteinase-21 gene and protein.
Marchenko GN
,
Marchenko ND
,
Strongin AY
.
???displayArticle.abstract???
Matrix metalloproteinases (MMPs) play key roles in tissue remodelling under normal development and, especially, in diseases ranging from malignancies to stroke. We cloned and thoroughly characterized the novel human and mouse MMP gene encoding MMP-21. MMP-21 is the last uncharacterized MMP coded by the human genome. Human and mouse MMP-21 is the orthologue of Xenopus laevis X-MMP. The latent proenzyme of MMP-21 (569 amino acid residues) consists of the prodomain, the catalytic domain and the haemopexin-like domain, and is potentially capable of being activated in its secretory pathway to the extracellular milieu by furin-like proprotein convertases. Human MMP-21 is the probable target gene of the Wnt pathway. In addition, the expression of MMP-21 is controlled uniquely by Pax and Notch transcription factors known to be critical for organogenesis. MMP-21 is expressed transiently in mouse embryogenesis and increased in embryonic neuronal tissues. Our observations clearly indicate that there is an important specific function for MMP-21 in embryogenesis, especially in neuronal cells.
Ahokas,
Matrix metalloproteinase-21, the human orthologue for XMMP, is expressed during fetal development and in cancer.
2002, Pubmed,
Xenbase
Ahokas,
Matrix metalloproteinase-21, the human orthologue for XMMP, is expressed during fetal development and in cancer.
2002,
Pubmed
,
Xenbase
Allenspach,
Notch signaling in cancer.
2002,
Pubmed
Allman,
Notch signaling in hematopoiesis and early lymphocyte development.
2002,
Pubmed
Barker,
Catenins, Wnt signaling and cancer.
2000,
Pubmed
Baron,
Multiple levels of Notch signal regulation (review).
2002,
Pubmed
Chi,
Getting your Pax straight: Pax proteins in development and disease.
2002,
Pubmed
Damjanovski,
Overexpression of matrix metalloproteinases leads to lethality in transgenic Xenopus laevis: implications for tissue-dependent functions of matrix metalloproteinases during late embryonic development.
2001,
Pubmed
,
Xenbase
De Strooper,
Where Notch and Wnt signaling meet. The presenilin hub.
2001,
Pubmed
Egeblad,
New functions for the matrix metalloproteinases in cancer progression.
2002,
Pubmed
Gu,
S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death.
2002,
Pubmed
Guidos,
Notch signaling in lymphocyte development.
2002,
Pubmed
Impola,
Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation.
2003,
Pubmed
Kajita,
Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration.
2001,
Pubmed
Leontovich,
A novel hydra matrix metalloproteinase (HMMP) functions in extracellular matrix degradation, morphogenesis and the maintenance of differentiated cells in the foot process.
2000,
Pubmed
Llano,
Dm1-MMP, a matrix metalloproteinase from Drosophila with a potential role in extracellular matrix remodeling during neural development.
2000,
Pubmed
Llano,
Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors.
1999,
Pubmed
Lohi,
Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury.
2001,
Pubmed
Marchenko,
MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors.
2001,
Pubmed
Marchenko,
Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin.
2001,
Pubmed
Marchenko,
Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin.
2002,
Pubmed
Marchenko,
Unconventional activation mechanisms of MMP-26, a human matrix metalloproteinase with a unique PHCGXXD cysteine-switch motif.
2002,
Pubmed
Massova,
Matrix metalloproteinases: structures, evolution, and diversification.
1998,
Pubmed
Mauch,
Matrix metalloproteinase-19 is expressed in myeloid cells in an adhesion-dependent manner and associates with the cell surface.
2002,
Pubmed
McQuibban,
Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.
2000,
Pubmed
Nagase,
Matrix metalloproteinases.
1999,
Pubmed
Ohnishi,
Cloning and characterization of a rat ortholog of MMP-23 (matrix metalloproteinase-23), a unique type of membrane-anchored matrix metalloproteinase and conditioned switching of its expression during the ovarian follicular development.
2001,
Pubmed
Overall,
Strategies for MMP inhibition in cancer: innovations for the post-trial era.
2002,
Pubmed
Park,
Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor.
2000,
Pubmed
Park,
Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26.
2002,
Pubmed
Pei,
Cysteine array matrix metalloproteinase (CA-MMP)/MMP-23 is a type II transmembrane matrix metalloproteinase regulated by a single cleavage for both secretion and activation.
2000,
Pubmed
Pei,
Furin-dependent intracellular activation of the human stromelysin-3 zymogen.
1995,
Pubmed
Ratnikov,
An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase.
2002,
Pubmed
Rozanov,
The cytoplasmic tail peptide sequence of membrane type-1 matrix metalloproteinase (MT1-MMP) directly binds to gC1qR, a compartment-specific chaperone-like regulatory protein.
2002,
Pubmed
Saarialho-Kere,
Epilysin (MMP-28) expression is associated with cell proliferation during epithelial repair.
2002,
Pubmed
Stracke,
Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme.
2000,
Pubmed
Suzuki,
Expression of a novel matrix metalloproteinase gene during Cynops early embryogenesis.
2001,
Pubmed
,
Xenbase
Uría,
Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity.
2000,
Pubmed
Velasco,
Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members.
1999,
Pubmed
Velasco,
Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
2000,
Pubmed
Westermarck,
Regulation of matrix metalloproteinase expression in tumor invasion.
1999,
Pubmed
Yang,
A novel matrix metalloproteinase gene (XMMP) encoding vitronectin-like motifs is transiently expressed in Xenopus laevis early embryo development.
1997,
Pubmed
,
Xenbase
de Coignac,
Cloning of MMP-26. A novel matrilysin-like proteinase.
2000,
Pubmed
